Trade Harrow Health, Inc. - HROW CFD

Trading Conditions

• Type: CFD
• Spread: 0.12
• Long position overnight funding adjustment: -0.02171%
• Short position overnight funding adjustment: -0.00052%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 34.86
• Open: 34.2
• 1-Year Change: 48.89%
• Day's Range: 34.2 - 35.3

What is Harrow Health, Inc. (HROW)?

Harrow Health, Inc. is a pharmaceutical company specializing in the development and commercialization of therapies for eye diseases. The company focuses on addressing unmet medical needs in ophthalmology, particularly conditions such as glaucoma, retinal diseases, and ocular inflammation. It operates through subsidiaries that engage in pharmaceutical development, manufacturing, and distribution. Harrow Health's portfolio includes branded and generic ophthalmic products, aiming to provide treatment options for chronic and acute eye conditions. The company also invests in research and development to advance novel drug candidates and delivery technologies. Its operations encompass regulatory compliance, clinical trials, and collaboration with healthcare providers to facilitate patient access to therapies. Harrow Health's business model integrates pharmaceutical innovation with commercial strategies to serve the ophthalmic market. The company is headquartered in the United States and participates in various aspects of the pharmaceutical supply chain, including drug formulation, manufacturing, and marketing within the eye care sector.

Harrow Health, Inc. Stock Price Today: Live Overview

The price today is shaped by trading activity for Harrow Health, Inc., currently valued at $35.30. The day's price range extends from $34.1 to $35.38, with a daily move of +0.8023%.

FAQ: Harrow Health, Inc. (HROW)

What is the current price of HROW stock?

Harrow Health, Inc. ended the day at $35.30.

Does HROW pay dividends?

Harrow Health, Inc. does not currently pay dividends.

Does HROW have a formal corporate presence or regional headquarters in the UAE?

Harrow Health, Inc. does not have an official office or subsidiary in the UAE and operates primarily in the US market.

What is HROW best known for?

The company is most famous for its ophthalmic pharmaceutical products.

What assets are typically shown together with HROW?

Commonly shown alongside HROW: AbbVie, Viatris Inc., Bausch Health Companies Inc.